Brief: Zyversa Therapeutics On June 9, Got Letter From Nasdaq Indicating That Co Is Not In Compliance With Continued Listing Rules
12/06/2023 11:47
June 12 (Reuters) - Zyversa Therapeutics Inc ZVSA.O :
* ZYVERSA THERAPEUTICS - ON JUNE 9, GOT LETTER FROM NASDAQ
INDICATING THAT CO IS NOT IN COMPLIANCE WITH CONTINUED LISTING
ON NASDAQ
Source text for Eikon: ID:
Further company coverage: ZVSA.O
Recent news on Zyversa Therapeutics
See all newsBrief: ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million
Brief: ZyVersa Unveils Potential Of Inflammasome Inhibitors In Combination With GLP-1 Agonists To Address Needs Of People Living With Obesity
Brief: Zyversa Therapeutics Announces Published Data Showing Inflammasome Asc Inhibitor IC 100 Decreases Microglial Inflammasome Activation
Brief: ZyVersa Therapeutics CEO Issues Shareholder Letter Announcing Transformative Research And Development Trends For Inflammasome Inhibitors, And Provides Update On Inflammasome ASC Inhibitor IC 100’S Development Status
Brief: Zyversa Therapeutics Files For Prospectus Related To Offer & Resale Of Up To 1.6 Million Shares Of Common Stock By Selling Stockholder - SEC Filing